Reactive oxygen species (ROS) have been implicated in the pathogenesis
of numerous disease processes. Epithelial cells lining the respirator
y airways are uniquely vulnerable regarding potential for oxidative da
mage due to their potential for exposure to both endogenous (e.g., mit
ochondrial respiration, phagocytic respiratory burst, cellular oxidase
s) and exogenous (e.g., air pollutants, xenobiotics, catalase negative
organisms) oxidants. Airway epithelial cells use several nonenzymatic
and enzymatic antioxidant mechanisms to protect against oxidative ins
ult. Nonenzymatic defenses include certain vitamins and low molecular
weight compounds such as thiols. The enzymes superoxide dismutase, cat
alase, and glutatione peroxidase are major sources of antioxidant prot
ection. Other materials associated with airway epithelium such as mucu
s, epithelial lining fluid, and even the basement membrane/extracellul
ar matrix may have protective actions as well. When the normal balance
between oxidants and antioxidants is upset, oxidant stress ensues and
subsequent epithelial cell alterations or damage may be a critical co
mponent in the pathogenesis of several respiratory diseases. Oxidant s
tress may profoundly alter lung physiology including pulmonary functio
n (e.g., forced expiratory volumes, flow rates, and maximal inspirator
y capacity), mucociliary activity, and airway reactivity. ROS may indu
ce airway inflammation; the inflammatory process may serve as an addit
ional source oi ROS in airways and provoke the pathophysiologic respon
ses described. On a more fundamental level, cellular mechanisms in the
pathogenesis of ROS may involve activation of intracellular signaling
enzymes including phospholipases and protein kinases stimulating the
release of inflammatory lipids and cytokines. Respiratory epithelium m
ay be intimately involved in defense against, and pathophysiologic cha
nges invoked by, ROS.